Zobrazeno 1 - 10
of 260
pro vyhledávání: ''
Autor:
Mingxuan Zhu, Zhuokai Zhuang, Yumo Xie, Ziying Huang, Yaoyi Huang, Dingcheng Shen, Juan Li, Huichuan Yu, Yanxin Luo, Xiaolin Wang, Rongzhao He, Meijin Huang
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 8924-8933 (2021)
Cancer Medicine
Cancer Medicine
Objective We conducted this multicenter cohort study to evaluate the current tumor‐node‐metastasis staging system and treatment modality by analyzing the survival outcomes of patient groups with stage III and IV colon cancer. Patients and Methods
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8483-8496 (2021)
Cancer Medicine
Cancer Medicine
Background The optimal treatment for elderly patients with esophageal cancer (EC) remains controversial. In the present study, we aimed to investigate whether elderly patients with stage II–III EC could benefit from trimodal therapy. Methods The se
Autor:
Jinyi Wang, Guohan Chen, Guangxue Wang, Xuan Hong, Zhiyuan Huang, Tian Zhao, Yejun Cao, Qiying Zhang, Zhengjun Chai, Jie Liu, Qinchuan Li, Yang Han, Zhengliang Sun
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 11, Iss 2, Pp 348-357 (2022)
Cancer Medicine, Vol 11, Iss 2, Pp 348-357 (2022)
Objective The aim of this study was to assess the efficacy and safety of intrapleural perfusion with hyperthermic chemotherapy (IPHC) in treating malignant pleural effusion (MPE) compared to normothermic chemoperfusion of the pleural cavity (NCPC), a
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 8909-8923 (2021)
Cancer Medicine
Cancer Medicine
Background There is limited and controversial evidence on the prognosis of partial nephrectomy (PN) versus radical nephrectomy (RN) in patients with T3aN0/xM0 renal cell carcinoma (RCC) upstaged from clinical T1 RCC. In this study, we aimed to assess
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 11, Iss 1, Pp 128-138 (2022)
Cancer Medicine, Vol 11, Iss 1, Pp 128-138 (2022)
Objective To investigate whether surgery improves prognosis in elderly patients with Merkel cell carcinoma (MCC). Materials/Methods Data of all patients with MCC diagnosed between 2004 and 2015 were extracted from the Surveillance, Epidemiology, and
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 74-85 (2022)
Cancer Medicine
Cancer Medicine
Objective This study was designed to establish and validate promising and reliable nomograms for predicting the survival of angiosarcoma (AS) patients. Methods The Surveillance, Epidemiology, and End Results database was queried to collect the clinic
Autor:
Wei Liu, Lisong Teng, Xiao Wang, Xiangyi Zheng, Jiazhu Sun, Liping Xie, Haixiang Shen, Jin Liu
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7492-7502 (2021)
Cancer Medicine
Cancer Medicine
Introduction Cytoreductive surgery is one of the recommended treatments for metastatic renal cell carcinoma, while the prognostic information of these patients treated with cytoreductive surgery is limited. In this study, we aimed to investigate the
Autor:
Jae Yong Park, Sook Kyung Do, Shin Yup Lee, Moon-June Cho, Jun-Sang Kim, Min Kyu Kang, Jin Eun Choi
Publikováno v:
Cancer Medicine, Vol 10, Iss 22, Pp 8071-8078 (2021)
Cancer Medicine
Cancer Medicine
Background To investigate the impact of programmed death‐ligand 1 (PD‐L1) polymorphisms on the prognosis of non‐small cell lung cancer (NSCLC) patients treated with curative radiotherapy. Methods Four single nucleotide polymorphisms (SNPs) (rs8
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7816-7830 (2021)
Cancer Medicine
Cancer Medicine
Background Computed tomography (CT)‐detected extramural venous invasion (EMVI) has been identified as an independent factor that can be used for risk stratification and prediction of prognosis in patients with gastric cancer (GC). Overall survival
Autor:
David Liska, Smitha S. Krishnamurthi, Alok A. Khorana, Kanika G. Nair, Nataly Valeria Torrejon, Suneel Deepak Kamath, Katherine Tullio, Wei Wei
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7542-7550 (2021)
Cancer Medicine
Cancer Medicine
Background The incidence of colorectal cancer (CRC) in patients under age 50 is rising for unclear reasons. We examined the effects of socioeconomic factors on outcomes for patients with early‐onset CRC compared to late‐onset CRC. Methods Patient